Aclid helps scientists build safer and better biomanufactured products. The world's leading biotech manufacturers and governments rely on Aclid's security and safety products for responsible research.

Aclid

Epizyme is a biopharmaceutical company that focuses on the discovery, development, and commercialization of novel epigenetic therapies for cancer and other diseases.

Epizyme

Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company developing novel epigenetic therapies to treat patients with cancer.

Constellation Pharmaceuticals

Mirati Therapeutics is a biotechnology company focused on the development of targeted oncology therapeutics.

Mirati Therapeutics

Aclid is a biotechnology company that specializes in the development of precision therapies for cancer and autoimmune diseases through the use of its proprietary SIGMA™ platform. The company focuses on discovering and targeting novel epigenetic and immune-modulatory mechanisms to create a new class of drugs.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 15, 2024 6:30 AM	b0bde5a6
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general
crunchbase trigger	general	Nov 27, 2024 12:50 PM	0d6b27f1
crunchbase profile	general
li profile	general	May 15, 2024 6:30 AM	6034f17b
translate crunchbase fundingrounds	general
peers	general
news basic	general
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BIO:ACLID

Aclid